Rheumatoid Arthritis Clinical Trials in Houston

Showing 1141-1160 of 1,660 trials

Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration

NCT01115231

Risk factors for Age-related Macular Degeneration (AMD) involves genetic variations in the alternative pathway of complement inhibitor factor H. The complement system is part of the innate and adaptive immune system. Smoking is the only environmental factor known to increase the risk of Age-related Macular Degeneration (AMD). Using serum samples of Age-related Macular Degeneration (AMD) patients and controls the investigators will test the hypothesis that smoking increases Age-related Macular Degeneration (AMD) by increasing complement activation; and that this is positively correlated with known disease variations in the complement factor H (CFH) gene.

Macular Degeneration

VA Office of Research and Development223 participantsStarted Oct 2010

Charleston, South Carolina, United States • Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

NCT01827046

A phase III, randomized, case-controlled, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage (ICH).

Intracerebral Hemorrhage

Johns Hopkins University499 participantsStarted Dec 2013

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +81 more locations

Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Rheumatoid Arthritis Trials in Other Cities

Soft Contacts Observation of Risk and Education (SCORE)

Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Primary Mitral Regurgitation Repair

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)

A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

Safety and Preliminary Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy

A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

Reevaluation Of Systemic Early Neuromuscular Blockade

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Other Conditions in Houston